Sun Pharma Canada Drug Patent Portfolio
Sun Pharma Canada owns 2 orange book drugs protected by 9 US patents Given below is the list of Sun Pharma Canada's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7799331 | Oral suspension of prednisolone acetate | 11 Oct, 2028 | Active |
| US8277780 | Stable liquid desoximethasone compositions with reduced oxidized impurity | 01 Sep, 2028 | Active |
| US8715624 | Stable liquid desoximethasone compositions with reduced oxidized impurity | 26 May, 2026 | Active |
| US6071523 | Spill resistant pharmaceutical compositions in semi-solid form | 03 Jun, 2018 | Expired |
| US6399079 | Spill resistant pharmaceutical compositions in semi-solid form | 03 Jun, 2018 | Expired |
| US6656482 | Spill resistant pharmaceutical system | 03 Jun, 2018 | Expired |
| US5990100 | Composition and method for treatment of psoriasis | 24 Mar, 2018 | Expired |
| US5881926 | Pharmaceutical compositions in semisolid form and a device for administration thereof | 16 Mar, 2016 | Expired |
| US6102254 | Pharmaceutical compositions in semisolid form and a device for administration thereof | 11 Mar, 2013 | Expired |
Latest Legal Activities on Sun Pharma Canada's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sun Pharma Canada.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Apr, 2024 | US8277780 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Mar, 2022 | US7799331 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 08 Nov, 2021 | US8715624 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Apr, 2020 | US8277780 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Feb, 2018 | US7799331 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Oct, 2017 | US8715624 (Litigated) |
|
Email Notification
Critical
| 09 Mar, 2017 | US7799331 |
|
Email Notification
Critical
| 09 Mar, 2017 | US8715624 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Mar, 2017 | US8715624 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Mar, 2017 | US7799331 |
|
Email Notification
Critical
| 07 Mar, 2017 | US8277780 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Mar, 2017 | US8277780 (Litigated) |
|
Correspondence Address Change
Critical
| 07 Mar, 2017 | US8715624 (Litigated) |
|
Correspondence Address Change
Critical
| 07 Mar, 2017 | US7799331 |
|
Correspondence Address Change
Critical
| 06 Mar, 2017 | US8277780 (Litigated) |
Sun Pharma Canada's Family Patents
Recently granted tentative Approvals to Sun Pharma Canada
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Sun Pharma Canada's portfolio.
Innovator tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Xyrosa | Doxycycline |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 3 - New Dosage Form | 26 Apr, 2017 |
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 14 Feb, 2013 |
| Atomoxetine Hydrochloride | Atomoxetine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 11 May, 2012 |
| Galantamine Hydrobromide | Galantamine Hydrobromide |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 28 Aug, 2007 |
Explore deeper patents analysis
Sun Pharma Canada Drug List
Given below is the complete list of Sun Pharma Canada's drugs and the patents protecting them.
1. Flo-pred
Flo-pred is protected by 6 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7799331 | Oral suspension of prednisolone acetate |
11 Oct, 2028
(2 years from now)
| Active |
| US6071523 | Spill resistant pharmaceutical compositions in semi-solid form |
03 Jun, 2018
(7 years ago)
| Expired |
| US6399079 | Spill resistant pharmaceutical compositions in semi-solid form |
03 Jun, 2018
(7 years ago)
| Expired |
| US6656482 | Spill resistant pharmaceutical system |
03 Jun, 2018
(7 years ago)
| Expired |
| US5881926 | Pharmaceutical compositions in semisolid form and a device for administration thereof |
16 Mar, 2016
(9 years ago)
| Expired |
| US6102254 | Pharmaceutical compositions in semisolid form and a device for administration thereof |
11 Mar, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flo-pred's drug page
2. Topicort
Topicort is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8277780 | Stable liquid desoximethasone compositions with reduced oxidized impurity |
01 Sep, 2028
(2 years from now)
| Active |
| US8715624 | Stable liquid desoximethasone compositions with reduced oxidized impurity |
26 May, 2026
(5 months from now)
| Active |
| US5990100 | Composition and method for treatment of psoriasis |
24 Mar, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Topicort's drug page